Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Completed · Phase 1

Conditions studied: Diabetic Macular Edema, Diabetic Retinopathy

In brief

The purpose of this study is to determine the safety and tolerability of MS-R001 at escalating doses in patients with diabetic macular edema secondary to diabetic retinopathy

Key facts

Study ID

NCT00401115

Run by

Santen Inc.

People needed

50

Starts

2006-09-01

Expected to finish

2008-06-01

Last updated by the study team

2010-07-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Retina Consultants of Arizona — Phoenix, Arizona, United States
• Texas Retina Associates — Arlington, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.